Kirkland Signature Smoked Salmon products recalled in October 2024 are now considered to be a Class 1 recall, the FDA’s most ...

Medexus will target a commercial launch in 1H CY2025; potential for annual product-level revenue to exceed US$100 million ...

Piper Sandler analyst Matt O'Brien increased the price target for Glaukos Corporation (NYSE:GKOS) shares to $180 from the previous target of $140, while maintaining an Overweight rating on the stock.

DURECT Corporation (Nasdaq: DRRX) today announced the publication of a peer-reviewed article on the AHFIRM trial data in NEJM ...

The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will take Accolade private.

GI Innovation announced on the 20th that it has signed a memorandum of understanding (MOU) with the Chinese bio company ...

Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications ...

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 7 includes Village Super Market, MARA Holdings, ...

There have been at least two reports of 'minor' allergic reactions linked to the sorbet sold in stores including Target and Wegmans, according to the Food and Drug Administration (FDA). The company ...

Mr. John DeLucia, as a well-respected Regulatory Consultant, is representing Izotropic in its pre-submission interactions with FDA while ensuring the Company's proposals, documentation, filings, and ...

The Food and Drug Administration is facing some backlash ... Vivek Ramaswamy have not been shy about about what they plan to target as their agency guides cut under Trump 2.0. Sen.

European markets closed higher on Friday, buoyed by robust Chinese growth data and merger talks in the mining sector.